| # | Drug | Count |
|---|---|---|
| 0 | ANAKINRA | 3 |
| 1 | CYCLOPHOSPHAMIDE | 3 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 3 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 3 |
| 4 | PREDNISONE | 3 |
| 5 | DEXAMETHASONE | 2 |
| 6 | DEXAMETHASONE 1.5 MG | 2 |
| 7 | DOXORUBICIN | 2 |
| 8 | FENTANYL | 2 |
| 9 | PREGABALIN | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BIVALIRUDIN | 1 | 0.0010 |
| 1 | SUGAMMADEX SODIUM | 1 | 0.0008 |
| 2 | ARGATROBAN | 1 | 0.0007 |
| 3 | VELAGLUCERASE ALFA | 1 | 0.0005 |
| 4 | GLOFITAMAB | 1 | 0.0004 |
| 5 | SUGAMMADEX | 1 | 0.0004 |
| 6 | BARICITINIB | 1 | 0.0003 |
| 7 | ANAKINRA | 3 | 0.0002 |
| 8 | SEVOFLURANE | 1 | 0.0001 |
| 9 | CANAKINUMAB | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 5 |
| 1 | Alkylating Drug [EPC] | 3 |
| 2 | Interleukin-1 Receptor Antagonist [EPC] | 3 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 2 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 2 |
| 5 | Opioid Agonist [EPC] | 2 |
| 6 | Amide Local Anesthetic [EPC] | 1 |
| 7 | Anti-coagulant [EPC] | 1 |
| 8 | Antiarrhythmic [EPC] | 1 |
| 9 | Aromatase Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anti-coagulant [EPC] | 1 | 0.0003 |
| 1 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 2 | Interleukin-1 Receptor Antagonist [EPC] | 3 | 0.0002 |
| 3 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 4 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 5 | Estrogen Receptor Antagonist [EPC] | 1 | 0.0000 |
| 6 | General Anesthetic [EPC] | 1 | 0.0000 |
| 7 | Ester Local Anesthetic [EPC] | 1 | 0.0000 |
| 8 | Non-Standardized Chemical Allergen [EPC] | 1 | 0.0000 |
| 9 | Alkylating Drug [EPC] | 3 | 0.0000 |